EXPORT LIST


A)  ACTIVE PHARMACEUTICAL INGREDIENTS (API)

L - CYSTEINE HCL,MONOHYDRATE, L - CYSTEINE HCL ANHYDROUS, CARBOCYSTEINE,
L- CYSTEINE, CYSTEINE BASE, N-ACETYL CYSTEINE, N-ACETYL TYROSINE, L-TYROSINE, L-LEUCINE, CARBAMAZEPINE, CARBOPOL

Amlodipine Besylate, Atorvastatin Calcium, Carvedilol, Celecoxib, Ciprofloxacin HCI,
Difloxacin, Enalpril Maleate, Enrofloxacin, Famotidine, Febantel, Fenbendazole,
Fluconazole, Fluoxetine HCI, Fluvastatin Sodium, Glibenclamide/Glyburide (Micronized)
Irbesartan, Itraconazole Pellets 22%, Itraconazole Powder, Lamivudine, Lansoprazole Powder

Lansoprazole Pellets 8.5%, Loratadine (Micronized), Losartan Potassium, Meloxicam
Norfloxacin, Omeprazole Pellets, Omeprazole Powder, Ornidazole, Paroxetine HCI
Rofecoxib, Sertraline HCI, Sildenafil Citrate, Tramadol HCI, Triclabendazole, Venlafaxine HCI
Candesartan (Under Development), Rabeprazole Sodium (Under Devlopment)
Piogilitazone (Under Pilot Scale), Glimeperide (Under Development)
Itavastatin (Under Development), Cerevastatin (Under Development)